• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质结构域的特异性共价抑制人类 DNA 聚合酶 β。

Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β.

机构信息

Department of Chemistry, Johns Hopkins University, 3400N. Charles St., Baltimore, MD 21218, USA.

Biomolecular NMR Center, Johns Hopkins University, Baltimore, MD 21218, USA.

出版信息

Chembiochem. 2021 Aug 17;22(16):2619-2623. doi: 10.1002/cbic.202100247. Epub 2021 Jul 8.

DOI:10.1002/cbic.202100247
PMID:34213836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8373715/
Abstract

DNA polymerase β (Pol β) is a frequently overexpressed and/or mutated bifunctional repair enzyme. Pol β possesses polymerase and lyase active sites, that are employed in two steps of base excision repair. Pol β is an attractive therapeutic target for which there is a need for inhibitors. Two mechanistically inspired covalent inhibitors (1, IC =21.0 μM; 9, IC =18.7 μM) that modify lysine residues in different Pol β active sites are characterized. Despite modifying lysine residues in different active sites, 1 and 9 inactivate the polymerase and lyase activities of Pol β. Fluorescence anisotropy experiments indicate that they do so by preventing DNA binding. Inhibitors 1 and 9 provide the basis for a general approach to preparing domain selective inhibitors of bifunctional polymerases. Such molecules could prove to be useful tools for studying the role of wild type and mutant forms of Pol β and other polymerases in DNA repair.

摘要

DNA 聚合酶 β(Pol β)是一种经常过表达和/或突变的双功能修复酶。Pol β 具有聚合酶和核酸内切酶活性位点,用于碱基切除修复的两个步骤。Pol β 是一个有吸引力的治疗靶点,需要抑制剂。两种基于机制的共价抑制剂(1,IC=21.0 μM;9,IC=18.7 μM),修饰不同 Pol β 活性位点中的赖氨酸残基,对其进行了表征。尽管修饰了不同活性位点中的赖氨酸残基,但 1 和 9 使 Pol β 的聚合酶和核酸内切酶活性失活。荧光各向异性实验表明,它们通过阻止 DNA 结合来实现这一点。抑制剂 1 和 9 为制备双功能聚合酶的结构域选择性抑制剂提供了一般方法的基础。这些分子可能被证明是研究野生型和突变型 Pol β 及其他聚合酶在 DNA 修复中的作用的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/d37fd985980c/CBIC-22-2619-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/c6c97fefc2ce/CBIC-22-2619-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/cef75f3f8af9/CBIC-22-2619-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/95e3d59c5f9f/CBIC-22-2619-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/73280f99b298/CBIC-22-2619-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/1bc526dbb944/CBIC-22-2619-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/43b17bb410af/CBIC-22-2619-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/d37fd985980c/CBIC-22-2619-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/c6c97fefc2ce/CBIC-22-2619-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/cef75f3f8af9/CBIC-22-2619-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/95e3d59c5f9f/CBIC-22-2619-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/73280f99b298/CBIC-22-2619-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/1bc526dbb944/CBIC-22-2619-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/43b17bb410af/CBIC-22-2619-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b8/8457197/d37fd985980c/CBIC-22-2619-g005.jpg

相似文献

1
Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β.蛋白质结构域的特异性共价抑制人类 DNA 聚合酶 β。
Chembiochem. 2021 Aug 17;22(16):2619-2623. doi: 10.1002/cbic.202100247. Epub 2021 Jul 8.
2
Selective Inhibition of DNA Polymerase β by a Covalent Inhibitor.共价抑制剂对 DNA 聚合酶 β 的选择性抑制。
J Am Chem Soc. 2021 Jun 2;143(21):8099-8107. doi: 10.1021/jacs.1c02453. Epub 2021 May 20.
3
Lysines in the lyase active site of DNA polymerase β destabilize nonspecific DNA binding, facilitating searching and DNA gap recognition.DNA 聚合酶 β 的裂解酶活性位点中的赖氨酸使非特异性 DNA 结合不稳定,从而促进搜索和 DNA 缺口识别。
J Biol Chem. 2020 Aug 21;295(34):12181-12187. doi: 10.1074/jbc.RA120.013547. Epub 2020 Jul 9.
4
Probing the Flexibility of the Catalytic Nucleophile in the Lyase Catalytic Pocket of Human DNA Polymerase β with Unnatural Lysine Analogues.用非天然赖氨酸类似物探究人DNA聚合酶β裂解酶催化口袋中催化亲核试剂的灵活性。
Biochemistry. 2017 Jan 24;56(3):500-513. doi: 10.1021/acs.biochem.6b00807. Epub 2017 Jan 12.
5
Lyase activities intrinsic to Escherichia coli polymerases IV and V.大肠杆菌聚合酶IV和V固有的裂合酶活性。
DNA Repair (Amst). 2005 Dec 8;4(12):1368-73. doi: 10.1016/j.dnarep.2005.08.005. Epub 2005 Oct 3.
6
DNA polymerase beta (pol β) inhibitors: a comprehensive overview.DNA 聚合酶 β(pol β)抑制剂:全面概述。
Drug Discov Today. 2012 Aug;17(15-16):913-20. doi: 10.1016/j.drudis.2012.04.008. Epub 2012 Apr 25.
7
Identification of small molecule synthetic inhibitors of DNA polymerase beta by NMR chemical shift mapping.通过核磁共振化学位移映射鉴定DNA聚合酶β的小分子合成抑制剂。
J Biol Chem. 2004 Sep 17;279(38):39736-44. doi: 10.1074/jbc.M402842200. Epub 2004 Jul 15.
8
NMR determination of lysine pKa values in the Pol lambda lyase domain: mechanistic implications.核磁共振法测定Pol λ裂解酶结构域中赖氨酸的pKa值:机理启示
Biochemistry. 2006 Feb 14;45(6):1785-94. doi: 10.1021/bi051856p.
9
Solution structure of the lyase domain of human DNA polymerase lambda.人类DNA聚合酶λ裂解酶结构域的溶液结构
Biochemistry. 2003 Aug 19;42(32):9564-74. doi: 10.1021/bi034298s.
10
Sulfoquinovosylmonoacylglycerol inhibitory mode analysis of rat DNA polymerase beta.大鼠DNA聚合酶β的磺基喹喔啉单酰甘油抑制模式分析
FEBS J. 2005 Sep;272(17):4349-61. doi: 10.1111/j.1742-4658.2005.04848.x.

引用本文的文献

1
Noncompetitive Inhibition of DNA Polymerase β by a Nonnative Nucleotide.一种非天然核苷酸对DNA聚合酶β的非竞争性抑制作用。
J Org Chem. 2025 Sep 7. doi: 10.1021/acs.joc.5c01529.

本文引用的文献

1
Selective Inhibition of DNA Polymerase β by a Covalent Inhibitor.共价抑制剂对 DNA 聚合酶 β 的选择性抑制。
J Am Chem Soc. 2021 Jun 2;143(21):8099-8107. doi: 10.1021/jacs.1c02453. Epub 2021 May 20.
2
Polymerase iota - an odd sibling among Y family polymerases.聚合酶iota——Y 家族聚合酶中的一个奇异兄弟。
DNA Repair (Amst). 2020 Feb;86:102753. doi: 10.1016/j.dnarep.2019.102753. Epub 2019 Nov 20.
3
Deployment of DNA polymerases beta and lambda in single-nucleotide and multinucleotide pathways of mammalian base excision DNA repair.
哺乳动物碱基切除 DNA 修复中单核苷酸和多核苷酸途径中 DNA 聚合酶β和λ的部署。
DNA Repair (Amst). 2019 Apr;76:11-19. doi: 10.1016/j.dnarep.2019.02.001. Epub 2019 Feb 4.
4
Targeting BER enzymes in cancer therapy.针对癌症治疗中的 BER 酶。
DNA Repair (Amst). 2018 Nov;71:118-126. doi: 10.1016/j.dnarep.2018.08.015. Epub 2018 Aug 25.
5
Mechanistic Insight through Irreversible Inhibition: DNA Polymerase θ Uses a Common Active Site for Polymerase and Lyase Activities.通过不可逆抑制获得的机制见解:DNA 聚合酶θ使用通用活性位点进行聚合酶和核酸外切酶活性。
J Am Chem Soc. 2018 Jul 25;140(29):9034-9037. doi: 10.1021/jacs.8b04158. Epub 2018 Jul 12.
6
Synergistic Effects of an Irreversible DNA Polymerase Inhibitor and DNA Damaging Agents on HeLa Cells.一种不可逆DNA聚合酶抑制剂与DNA损伤剂对HeLa细胞的协同作用
ACS Chem Biol. 2018 Mar 16;13(3):832. doi: 10.1021/acschembio.8b00048. Epub 2018 Jan 25.
7
DNA polymerase beta participates in DNA End-joining.DNA 聚合酶β参与 DNA 末端连接。
Nucleic Acids Res. 2018 Jan 9;46(1):242-255. doi: 10.1093/nar/gkx1147.
8
Drugging the Cancers Addicted to DNA Repair.对依赖DNA修复的癌症进行药物治疗。
J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx059.
9
Synergistic Effects of an Irreversible DNA Polymerase Inhibitor and DNA Damaging Agents on HeLa Cells.一种不可逆DNA聚合酶抑制剂与DNA损伤剂对HeLa细胞的协同作用
ACS Chem Biol. 2017 Jun 16;12(6):1576-1583. doi: 10.1021/acschembio.7b00259. Epub 2017 May 1.
10
Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells.厚朴酚抑制DNA聚合酶β和λ并增强人癌细胞对博来霉素的敏感性。
Chem Res Toxicol. 2017 Feb 20;30(2):715-725. doi: 10.1021/acs.chemrestox.6b00451. Epub 2017 Jan 19.